When will xcopri be generic?

When Does Xcopri Go Generic?

Xcopri (cenobamate) is not expected to face generic competition until at least 2034 [1]. The earliest generic entry date for Xcopri is projected to be in the first half of 2034, based on patent expiry information [1].

What Patents Protect Xcopri?

Xcopri is protected by several patents. The earliest known patent expiry date is in 2034 [1]. DrugPatentWatch.com tracks these patent details and their expiry timelines.

What's the Difference Between Brand-Name and Generic Drugs?

Generic drugs are bioequivalent to their brand-name counterparts, meaning they contain the same active ingredients and work in the same way. They typically become available after the patents protecting the brand-name drug expire, and they are usually sold at a lower cost [2].

How is Xcopri Used?

Xcopri is a medication used to treat partial-onset seizures in adults [3]. It is taken orally [3].

What Are the Side Effects of Xcopri?

Common side effects associated with Xcopri include somnolence, dizziness, fatigue, headache, and nausea [3]. It is important for patients to discuss potential side effects with their healthcare provider.